spot_img
Sunday, August 14, 2022
More
    HomeHealthSTAT+: Out-of-pocket spending for hepatitis B meds kept rising, despite generic competition

    STAT+: Out-of-pocket spending for hepatitis B meds kept rising, despite generic competition

    -



    File this underneath ‘How curious.’

    After  generic variations of a key hepatitis B therapy debuted in 2014, they helped sufferers lower your expenses over the following few years. But on the identical time, the common out-of-pocket spending on these generics really rose, regardless that almost a dozen copycat variations had been accessible, suggesting competitors did not work sufficiently.

    Continue to STAT+ to read the full story…



    Source link

    Related articles

    Stay Connected

    0FansLike
    0FollowersFollow
    3,436FollowersFollow
    0SubscribersSubscribe
    spot_img

    Latest posts